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N E U R O S C I E N C E
Astrocyte dysfunction increases cortical  
dendritic excitability and promotes cranial pain 
in familial migraine
Jennifer Romanos1,2, Dietmar Benke1,2, Daniela Pietrobon3,4,  
Hanns Ulrich Zeilhofer1,2,5, Mirko Santello1,2*
Astrocytes are essential contributors to neuronal function. As a consequence, disturbed astrocyte-neuron interactions 
are involved in the pathophysiology of several neurological disorders, with a strong impact on brain circuits and 
behavior. Here, we describe altered cortical physiology in a genetic mouse model of familial hemiplegic migraine 
type 2 (FHM2), with reduced expression of astrocytic Na+,K+-ATPases. We used whole-cell electrophysiology, 
two-photon microscopy, and astrocyte gene rescue to demonstrate that an impairment in astrocytic glutamate 
uptake promotes NMDA spike generation in dendrites of cingulate cortex pyramidal neurons and enhances output 
firing of these neurons. Astrocyte compensation of the defective ATPase in the cingulate cortex rescued glutamate 
uptake, prevented abnormal NMDA spikes, and reduced sensitivity to cranial pain triggers. Together, our results 
demonstrate that impaired astrocyte function alters neuronal activity in the cingulate cortex and facilitates 
migraine-like cranial pain states in a mouse model of migraine.
INTRODUCTION
Astrocytes closely interact with neurons and strongly affect their 
functions at the synaptic, cellular, and circuit levels (1). Defective 
neuron-astrocyte interactions have been implicated in the establish-
ment and development of several neurological disorders (1–3). 
Migraine is an extremely debilitating disease characterized by re-
current unilateral and severe headaches, frequently accompanied 
with several other neurological symptoms (4). However, migraine is 
much more than an episodic pain disorder. Several findings indeed 
suggest that migraine is a disease affecting a large part of the central 
nervous system and characterized by a global dysfunction in sensory 
information processing and integration, which also occurs between 
migraine episodes (interictal period) (5). For example, patients with 
migraine exhibit increased cortical responses to noxious and non- 
noxious sensory stimuli during the interictal period (6, 7). At present, 
the cellular mechanisms responsible for these alterations are largely 
unknown. Astrocytes have been proposed to play a role in some 
inherited forms of migraine, including familial hemiplegic migraine 
type 2 (FHM2), an autosomal dominant form of migraine with aura. 
FHM2 is caused by mutations in the Atp1a2 gene, which encodes 
the a2 subunit of the Na
+, K+-dependent adenosine triphosphatase 
(ATPase) (a2 NKA) (8), an isoform that is almost exclusively ex-
pressed in astrocytes in the adult brain (9). Expression of the a2 
NKA is reduced in the heterozygous Atp1a2+/R887 FHM2 knock-in 
(KI) mice, which carry an Atp1a2 missense mutation, causing a 
complete loss of function of recombinant a2 NKA (8, 10). We pre-
viously showed that these FHM2 mice display impaired glutamate 
and K+ clearance by astrocytes of the primary somatosensory cortex, 
which, in turn, promotes cortical spreading depression (CSD), the 
neuronal correlate of the aura symptoms that precede migraine 
headache (3).
In this study, we took advantage of the FHM2 KI mouse model 
to understand whether and how a mutation in an astrocyte-specific 
protein affects neuronal functions in the cingulate cortex (Cg). This 
cortical region is crucial for pain processing and displays altered 
functionality in patients with migraine (7, 11–13). We show that 
impairment in astrocytic glutamate uptake in this region strongly 
enhances cortical dendritic excitability, especially the generation 
of N-methyl-D-aspartate (NMDA) spikes in layer 5 (L5) pyramidal 
neurons, and enhances their output firing. Moreover, we reveal that 
FHM2 mice display increased sensitivity to head pain triggers. Last, 
we show that rescuing the disease-causing mutation in astrocytes of 
the Cg recovers neuronal function and reduces the pain phenotype. 
Our results provide a clear example of how astrocyte dysfunction 
produced by a genetic defect affects neuronal activity in the Cg and 
affects sensitivity to head pain triggers.
RESULTS
Astrocytic dysfunctions in the Cg of FHM2 mice
The a2 NKA is physically and functionally coupled to glutamate trans-
porters (GluTs) expressed on perisynaptic astrocyte processes (9, 14). 
The reduced expression of a2 NKA in heterozygous Atp1a2
+/R887 
mice (FHM2 mice) results in a reduction in glutamate and K+ buffering 
capacity of astrocytes in the primary somatosensory cortex (3, 10). 
To investigate FHM2-associated alterations in glutamate and K+ 
uptake in the Cg, a brain region crucially involved in pain process-
ing, we performed whole-cell patch-clamp recordings from astro-
cytes in acute cortical slices (Fig. 1A). We recorded synaptically evoked 
GluT currents (STCs) and K+ uptake currents induced by electrical 
stimuli to L1 afferent fibers with an extracellular electrode and 
applied different stimulation paradigms (single pulses and pulse 
trains at 50 and 100 Hz; Fig. 1, A and B). Glutamate uptake was 
significantly slower in the Cg of FHM2 mice compared to their 
wild-type (WT) littermates, which was reflected by higher STC decay 
time constants (t) [Fig. 1, C and D; single pulse: WT tdecay = 3.11 ± 0.15 ms 
1Institute of Pharmacology and Toxicology, University of Zurich, CH-8057 Zurich, 
Switzerland. 2Neuroscience Center Zurich, University of Zurich and ETH Zurich, CH-8057 
Zurich, Switzerland. 3Department of Biomedical Sciences and Padova Neuroscience 
Center, University of Padova, 35131 Padova, Italy. 4CNR Institute of Neuroscience, 
Via Ugo Bassi 58/B, 35131 Padova, Italy. 5Institute of Pharmaceutical Sciences, ETH 
Zurich, CH-8093 Zurich, Switzerland.
*Corresponding author. Email: mirko.santello@pharma.uzh.ch
Copyright © 2020 




for the Advancement 
of Science. No claim to 
original U.S. Government 
Works. Distributed 
under a Creative 
Commons Attribution 
License 4.0 (CC BY).
Romanos et al., Sci. Adv. 2020; 6 : eaaz1584     5 June 2020
S C I E N C E  A D V A N C E S  |  R E S E A R C H  A R T I C L E
2 of 13
(n = 10 cells, N = 5 mice) and FHM2 tdecay = 3.69 ± 0.15 ms (n = 14, 
N = 8; *P = 0.017); 50 Hz: WT tdecay = 2.81 ± 0.11 ms (n = 10) and 
FHM2 tdecay = 3.34 ± 0.18 ms (n = 13; *P = 0.029); 100 Hz: WT 
tdecay = 2.54 ± 0.13 ms (n = 10) and FHM2 tdecay = 3.22 ± 0.18 ms 
(n = 13; **P = 0.009)]. The decay kinetics of the K+ currents following 
a train of pulses at 100 Hz were also significantly slower in the FHM2 
mice [Fig. 1E; WT tdecay = 1.72 ± 0.08 s (n = 7 cells, N = 4 mice) and 
FHM2 tdecay = 2.25 ± 0.18 s (n = 10, N = 5 mice; *P = 0.03)]. We 
observed no difference in astrocytic resting membrane potential 
nor input resistance between the two groups (fig. S1). These data 
indicate that in the Cg of adult FHM2 mice, astrocytic uptake of 
neuron-derived glutamate and K+ was impaired.
Slower glutamate clearance by astrocytes may lead to prolonged 
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Fig. 1. Aberrant astrocytic glutamate and K+ uptake in the Cg of FHM2 mice. (A) Schematic representation of the experiment. Scale bar, 30 mm. (B) Superimposed 
representative traces of the inward current evoked in an astrocyte with different stimulation patterns. (C) The decay time of inward currents evoked by single-pulse stim-
ulation is slower in FHM2 mice (red) compared to WT mice (black). (D) The average STC decay times of the last pulse of the trains at 50 (left) and 100 Hz (right) are signifi-
cantly slower in FHM2 mice. Each point represents the STC decay time in one astrocyte. (E) Decay kinetics of the K+ inward current following trains of 100 Hz stimulation 
are slower in FHM2 mice. (F) Injection of AAV.GFAP.iGluSnFr unilaterally in the Cg of WT and FHM2 mice. A typical two-photon experiment showing the expression of 
iGluSnFr on astrocytes in the Cg (green) and sulforhodamine 101 dye (SR-101; red) is shown. The theta glass electrode for synaptic stimulation is placed in the inner L1, 
and glutamate is imaged from an ROI adjacent to the electrode. Scale bar, 40 mm. (G) Upon trains of synaptic stimulation (10 × 50 Hz and 10 × 100 Hz), robust and reliable 
increases in iGluSnFr emission could be detected. The decay kinetics of the averaged transients are slower in FHM2 mice. Representative traces are the average of at least 
five sweeps. Data are means ± SEM. Two-tailed unpaired t test was used.
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test this prediction, we took advantage of the intensity-based glutamate 
fluorescent sensor iGluSnFr (15) that we expressed on the extracellular 
side of the astrocytic plasma membrane (Fig. 1F and see Materials 
and Methods). Two-photon imaging of iGluSnFr glutamate signals 
allowed the study of the time course of extracellular glutamate follow-
ing synaptic stimulation. Synaptic activity was evoked by focal electrical 
stimulation in L1 of the Cg, and glutamate was imaged in a region of 
interest (ROI) in the proximity of the stimulation electrode (Fig. 1F). 
To estimate the speed of glutamate clearance, we fitted the decay of 
the averaged evoked glutamate transients (10 trials) with a monoex-
ponential curve (16). We found that synaptically evoked iGluSnFr 
transients in the adult Cg were sensitive to minor changes in the 
activity of astrocytic GluTs. Accordingly, partial blockade of GluTs 
with subsaturating concentrations of threo-beta-Benzyloxyaspartate 
(DL-TBOA) (3 mM), a concentration that mimics in WT mice the 
slowing of STC decay kinetics produced by the FHM2 mutation (3), 
increased the decay time constant of extracellular glutamate transients 
in WT mice (fig. S2).
We subsequently recorded iGluSnFr signals in the Cg of FHM2 
mice and compared it with WT littermates. The iGluSnFr signals 
displayed a longer time course following trains of 50 and 100 Hz 
stimulations in the FHM2 mice, which were 32 and 29% slower, 
respectively [Fig. 1G; 50 Hz: WT tdecay = 75.56 ± 3.62 ms (n = 13 
slices, N = 5 mice) and FHM2 tdecay = 100.9 ± 5.33 ms (n = 22, N = 7; 
**P = 0.0019); 100 Hz: WT tdecay = 65.6 ± 3.32 ms (n = 14) and FHM2 
tdecay = 84.57 ± 4.77 ms (n = 22; **P = 0.006)]. Note that we and 
others have previously demonstrated that the size and location of 
ROIs, stimulation intensity, and sulforhodamine 101 dye (SR-101) 
do not influence the iGluSnFr decay kinetics (16, 17). Overall, these 
experiments demonstrate that in the adult Cg, astrocytes carrying 
the W887R a2 NKA mutation responsible for FHM2 display defective 
glutamate and K+ buffering capacity upon repetitive synaptic stim-
ulation, which results in temporally prolonged glutamate spillover.
Facilitation of NMDA spike generation in L5 pyramidal 
neurons of FHM2 mice
Pharmacological reduction of astrocytic glutamate uptake capacity 
in the cortex increases extracellular buildup of glutamate, which 
directly affects NMDA receptor activation in L5 pyramidal neurons 
(17). In addition, glutamate spillover promotes the occurrence of 
NMDA dendritic spikes (18). These spikes are local events (de-
polarizations) caused by the regenerative and voltage-dependent 
activation of NMDA receptors in specific dendritic branches and 
have been shown to strongly promote pyramidal cell firing in vivo 
(19). We tested whether the alteration of astrocytic glutamate clearance 
in FHM2 mice would affect NMDA spike generation. We evoked 
NMDA spikes in the distal dendrites of L5 pyramidal neurons by 
focal synaptic stimulation (paired pulse, 50 Hz) in close proximity 
to single branches of tuft dendrites in L1 of the Cg (Fig. 2A). In-
creasing stimulation intensities caused a nonlinear increase in the 
amplitude and area under the curve (AUC) of the second pulse, 
which is characteristic of NMDA spikes (20). This nonlinear increase 
was abolished in the presence of NMDA receptor blocker D,L-2- 
amino-5-phosphonovaleric acid (AP-V) (Fig. 2B).
As predicted from the reduced glutamate clearance in FHM2 mice, 
these mice displayed facilitated NMDA spike generation reflected 
by higher amplitude and AUC of the voltage responses evoked by 
L1 synaptic stimulations [Fig. 2C; second pulse amplitude: WT, 
1.56 ± 0.4 mV (n = 12 cells, N = 8 mice) and FHM2, 9.13 ± 2.48 mV (n = 13, 
N = 6; ***P < 0.0001); second pulse AUC: WT, 40.64 ± 13.9 mV ms 
(n = 11) and FHM2, 411.5 ± 131 mV ms (n = 12; *P < 0.05); stimula-
tion intensity, 2 mA]. Partial blockade of GluTs with subsaturating 
concentrations of the GluT blocker DL-TBOA (3 mM) significantly 
enhanced NMDA spike generation in L5 pyramidal neurons in WT 
mice (fig. S3), mimicking the effect of the FHM2 genetic mutation.
Dendritic NMDA spikes have been reported to promote somatic 
firing in neurons of the somatosensory cortex (19). The main apical 
dendrite of L5 pyramidal neurons of the Cg displays a remarkably 
low dendrite-to-soma attenuation of slow synaptic inputs compared to 
other cortical regions (21), suggesting that NMDA-mediated dendritic 
depolarizations may have an even stronger influence on somatic depo-
larization and action potential (AP) firing in this region. We find that 
our NMDA spike induction protocol easily triggered somatic firing 
(Fig. 2D). Consequently, we predicted that the facilitation of NMDA 
spikes that we identified in FHM2 Cg L5 pyramidal neurons should 
lead to increased firing of these neurons. We found that the probability 
of AP firing following NMDA spikes was significantly higher in FHM2 
mice compared to their WT littermates (Fig. 2D). These data demon-
strate that in the Cg, defective glutamate uptake and the prolonged 
presence of synaptically released glutamate are accompanied by a fa-
cilitation in NMDA spikes and somatic firing of L5 pyramidal cells.
We then investigated whether synaptic activity is altered in FHM2 
mice. We first recorded miniature excitatory postsynaptic currents 
(mEPSCs) from L5 pyramidal cells of WT and FHM2 mice 
(Fig. 3, A, B, and C) and found no change in baseline synaptic activity 
(mEPSC frequency and amplitude) between the two groups [mEPSC 
frequency: WT, 3.02  ±  0.71  Hz (n  =  7 cells) and FHM2 KI, 
4.53 ± 1.54 Hz (n = 9 cells; P = 0.43); mEPSC amplitude: WT, 
14.81 ± 1.35 pA and FHM2 KI, 13.09 ± 0.82 pA (P = 0.27)]. We 
additionally recorded AMPA-mediated EPSCs evoked with single- 
pulse and paired-pulse extracellular synaptic stimulations (Fig. 3, D and E). 
Upon single-pulse stimulations, both the amplitude and decay 
kinetics of EPSCs were similar in WT and FHM2 mice [amplitude: 
WT, −117 ± 18.04 pA (n = 7 cells) and FHM2 KI, −118.6 ± 12.03 pA 
(n = 6 cells; P = 0.94); decay: WT, 17.7 ± 2.1 ms (n = 7 cells) and 
FHM2 KI, 18.29 ± 1.4 ms (n = 6 cells; P = 0.82)]. Similarly, upon 
paired-pulse stimulation at 20 Hz, the second-over-first EPSC 
amplitude ratio was comparable in WT and FHM2 mice [second/
first amplitude ratio: WT, 1.73 ± 0.09 (n = 7 cells) and FHM2, 
1.54 ± 0.08 (n = 7 cells; P = 0.17)]. These datasets strongly argue 
against alterations in glutamate release or in AMPA-mediated 
synaptic transmission in the Cg of FHM2 mice.
Local astrocytic defects are responsible for NMDA-mediated 
neuronal dysfunctions
Excitatory neuronal activity appears to be highly increased in the 
Cg of FHM2 mice. Nevertheless, to what extent the local astrocytic 
malfunction is responsible for the modifications in neuronal activity 
is not clear. To address this question, we compensated for the astro-
cyte dysfunction in the Cg region of FHM2 mice by expressing the 
WT form of a2 NKA (Atp1a2) in astrocytes. To deliver Atp1a2, 
we used an adeno-associated virus (AAV) of the 5/2 serotype that 
preferentially targets astrocytes and took advantage of the astrocyte 
promoter hGFAP (AAV.hGFAP.ATP1A2) (22). As a control, AAV 
of the same serotype and with the same vector backbone, but 
containing only enhanced green fluorescent protein (eGFP) 
(AAV.hGFAP.eGFP), was injected (Fig. 4A; also see Materials and 
Methods). Since AAV vectors’ size is limited to ~4.7 kb, it was not possible 
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to include a reporter gene in the virus with ATP1A2. Therefore, to visualize 
the injection site, we injected a mixture of 0.5 ml of the two viruses 
with a ratio of 2:1 of AAV.hGFAP.ATP1A2 to the control virus 
(AAV.hGFAP.eGFP). Two to 3 weeks following injections, immuno-
histochemistry experiments showed that AAV.hGFAP targeted 
astrocytes with no apparent neuronal expression (fig. S4). Consistent 
with previous findings on other brain regions (10), the Cg of FHM2 
mice showed a substantial reduction of a2 NKA expression levels 
(about 70%) compared to WT littermates (fig. S5A). This reduction 
was significantly, albeit not fully, restored in FHM2 mice injected 
with the rescue virus (fig. S5A). The Western blot experiments were 
performed 15 days post-injection (d.p.i.) of the viruses. Accordingly, 
the functional recovery of the STC decay kinetics was also incomplete 
at 15 d.p.i. (fig. S6). This may, at least in part, account for the incomplete 
restoration of a2 NKA expression. For this reason, the functional and 
behavioral experiments (see later) were performed mostly at 21 d.p.i., when 
the STC decay kinetics became similar to WT levels (fig. S6). In addition, 
it is also likely that the Cg tissue extracted for Western blot analysis con-
tained regions with a mixture of high and low (or no) virus expression.
We additionally evaluated the expression levels of the astrocytic 
GluTs, GLT-1 and GLAST, that both play a crucial role in glutamate 
uptake in the Cg (17). We observed a 25% reduction of GLAST ex-
pression in the Cg of FHM2 mice, which was restored to WT levels in 
FHM2 mice injected with the rescue virus (fig. S5B). On the other 
hand, no changes in GLT-1 expression levels were observed between 
the different groups (fig. S5C).
We then performed electrophysiological recordings in the same 
manner as in Fig. 1 from FHM2 astrocytes either expressing WT Atp1a2 
or the eGFP control. Our data show that both K+ [Fig. 4B; control tdecay = 
2.66 ± 0.16 s (n = 9 cells, N = 4 mice) and rescue tdecay = 2.14 ± 0.13 s 
(n = 10, N = 4; *P = 0.02)] and active glutamate clearance by astrocytes 
became significantly faster in FHM2 mice in which WT Atp1a2 was 
expressed compared to FHM2 mice that were injected with the control 
virus [Fig. 4C; single pulse: control tdecay = 3.3 ± 0.06 ms (n = 10 cells, 
N = 4 mice) and rescue tdecay = 2.6 ± 0.13 ms (n = 12, N = 4; 
***P = 0.0003); 50 Hz: control tdecay = 3.24 ± 0.06 ms (n = 10) and 
rescue tdecay = 2.46 ± 0.18 ms (n = 12, **P = 0.001); 100 Hz: control 
tdecay = 3.11 ± 0.04 ms (n = 10) and rescue tdecay = 2.31 ± 0.12 ms 
(n = 12; ***P = 0.0001)]. The decay kinetics of the uptake currents in the 
rescued FHM2 mice became comparable to those observed in WT mice 
(fig. S7A). The astrocytic resting membrane potential was slightly 
but significantly hyperpolarized in rescued FHM2 mice compared 




























































































































Fig. 2. Facilitation of NMDA spike generation in L5 pyramidal neurons in the Cg of FHM2 mice. (A) Image of whole-cell recording from the soma of a biocytin-labeled 
L5 pyramidal cell in the Cg showing the location of the recording pipette (L5) and stimulation electrode (in close proximity to single branches of tuft dendrites in L1 of the 
Cg). Scale bar, 50 mm. (B) Representative traces of NMDA spikes evoked by focal synaptic stimulation (paired pulse, 50 Hz) of increasing stimulation intensities that cause 
an abrupt and nonlinear increase in amplitude and AUC of the second pulse, which is characteristic of NMDA spikes. This nonlinear increase is abolished in the presence 
of NMDA receptor blocker AP-V (50 mM; box). (C) The amplitude and the AUC of the second pulse are significantly higher in FHM2 mice compared to WT mice upon lower 
stimulation intensities. (D) Paired-pulse stimulation had a higher probability to evoke a somatic action potential (AP) in FHM2 mice. Data are means ± SEM. Two-way 
analysis of variance (ANOVA) with Bonferroni post hoc test and Z score were used.
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In light of these results, we investigated whether the rescue of the 
astrocytic dysfunctions could indeed affect the neuronal defects 
observed in FHM2 mice. To this end, we evoked NMDA spikes in the 
distal dendrites of L5 pyramidal neurons by focal synaptic stimula-
tion as in previous experiments (Fig. 4, D and E). The amplitude and 
AUC of NMDA spikes were significantly lower in FHM2 mice in-
jected with WT Atp1a2 compared to FHM2 mice injected with the 
control virus [Fig. 4F; second pulse amplitude: control, 12.56 ± 2.11 mV 
(n = 7 cells, N = 3 mice) and rescue, 4.8 ± 1.52 mV (n = 11, N = 4; 
***P < 0.0001); second pulse AUC: control, 432.7 ± 87.7 mV ms 
(n = 7) and FHM2, 198.15 ± 69 mV ms (n = 12; **P < 0.01); stimu-
lation intensity, 2.5 mA]. The values in the rescued FHM2 mice were 
comparable to those in WT mice (fig. S7B). This rescue was also 
accompanied by a significantly lower probability of AP firing follow-
ing NMDA spikes in the rescued FHM2 mice (Fig. 4G).
Local astrocyte dysfunction in the Cg influences orofacial 
pain in FHM2 mice
The Cg is a critical cortical region in encoding cephalic pain. Altered 
neuronal activity in this brain area has been reported to influence 
the activation and sensitization of pain pathways in pathological pain 
conditions (23). Whether local astrocyte dysfunction in the Cg can 
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Fig. 3. Baseline synaptic activity is similar in L5 pyramidal cells of FHM2 and WT mice. (A) Representative example traces (6 s) of whole-cell mEPSCs recordings from 
WT mice (left) and FHM2 KI mice (right). Average mEPSCs are shown above the traces. (B) Cumulative frequency plots of interevent intervals (IEI) (left) from WT and FHM2 
KI and cumulative frequency plot of mEPSCs amplitudes from the same cells (right) calculated from the presented traces above. (C) No difference is observed in mEPSCs 
frequency between WT and FHM2 KI slices. Data points represent individual cells. (D) Left: Example traces of AMPA-mediated evoked EPSCs following a single pulse in WT 
(black) and FHM2 mice (red). Right: The amplitude of EPSCs following a single pulse is similar in WT and FHM2 mice. Decay kinetics are also similar in WT and FHM2 KI mice. 
(E) Left: Example traces of AMPA-mediated evoked EPSCs following a paired-pulse stimulation at 20 Hz in WT and FHM2 mice. Right: The second-to-first EPSC amplitude 
ratio is not different in WT compared to FHM2 mice. Data are means ± SEM. Two-tailed unpaired t test was used.
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Fig. 4. Local astrocytic defects are responsible for NMDA-mediated neuronal dysfunctions. (A) AAVs containing the WT form of Atp1a2 (AAV5/2.hGFAP.ATP1A2) or 
a control virus (AAV5/2.hGFAP.eGFP) is unilaterally injected in the Cg of FHM2 mice. At 21 d.p.i., astrocytes expressing either GFP or Atp1a2 in L1 of the Cg cortex are 
targeted for recording in acute brain slices while stimulating nearby neurons. Scale bar, 40 mm. (B) Example traces of the K+ current following trains of 100 Hz stimulations 
in FHM2 mice injected with the control virus (red) and those injected with the rescue virus (blue). The decay kinetics of K+ currents are significantly faster in rescued FHM2 
mice compared to control FHM2 mice. (C) Upon all stimulation patterns (single pulse and trains of 50 and 100 Hz), the decay kinetics of STCs are faster in rescued mice 
compared to the control group. (D) Image of whole-cell recording from the soma of a biocytin-labeled L5 pyramidal cell in the Cg surrounded by eGFP-expressing astro-
cytes. Scale bar, 40 mm. (E) Representative traces of NMDA spikes evoked by focal synaptic stimulation (paired pulse, 50 Hz) in control FHM2 mice (red) and in rescued 
FHM2 mice (blue). (F) Both the amplitude and the AUC of the second pulse are significantly lower in rescued FHM2 mice compared to the control group. (G) Paired-pulse 
stimulation had a lower probability to evoke a somatic AP in rescued FHM2 mice (blue) compared to control mice (red). Data are means ± SEM. Two-tailed unpaired t test, 
two-way ANOVA with Bonferroni post hoc test, and Z score were used.
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facilitate cranial pain in FHM2 mice is unknown. To explore this 
possibility, we activated the cranial pain pathway via a single systemic 
injection of the nitric oxide donor nitroglycerin (NTG). NTG is con-
sidered a reliable cranial pain trigger especially in migraine-susceptible 
patients. Only in patients with migraine, NTG induces a delayed 
migraine-like headache with associated features (e.g., premonitory 
symptoms) that resemble their own spontaneous migraine attacks 
(24). Systemic injections of NO donors have also been used in rodents 
(25) and have been shown to evoke hypersensitivity to touch (typical 
migraine symptom), particularly in mice carrying a mutation associated 
with migraine with aura (26). To assess the development of facial 
mechanical sensitization upon NTG injections, we gently poked the 
mice in the orofacial region with von Frey filaments and scored the 
evoked nocifensive behavior (orofacial pain score; see Materials and 
Methods). This scoring system has been previously used to assess 
trigeminal neuropathic pain in rodent models (27). We first found 
that NTG [10 mg kg−1, intraperitoneally (i.p.)] triggered facial 
mechanical hypersensitivity in both WT and FHM2 mice at 30, 60, and 
120 min post NTG injection compared to mice injected with saline 
[Fig. 5, B and C; AUC for WT: saline, 67.56 ± 12.50 (N = 6 mice) 
and NTG, 165.5 ± 19.08 (N = 6; **P = 0.0016); AUC for FHM2: 
saline, 71.32 ± 11.72 (N = 6) and NTG, 190.3 ± 23.92 (N = 6; 
**P = 0.0012)]. FHM2 mice developed orofacial hypersensitivity upon 
NTG doses that were ineffective in WT littermates [5 mg kg−1; 
Fig. 5, D and E; AUC for WT: saline, 91.51 ± 19.11 (N = 6 mice) and 
NTG, 58.90 ± 8.88 (N = 8; P = 0.12); AUC for FHM2: saline, 
67.16 ± 20.29 (N = 7) and NTG, 146.0 ± 13.13 (N = 7; **P = 0.0068)]. 
These results suggest that the FHM2 mutation promotes the develop-
ment of NTG-induced facial mechanical hypersensitivity. The 
same phenotype was observed with a lighter von Frey filament of 
0.025 g (fig. S9). Activity tests showed no difference between 
saline- and NTG-treated mice or between FHM2 and WT litter-
mates, suggesting that the different responses to mechanical 
stimulation were not accompanied by alterations in motor func-
tion (fig. S10, A and B).
Since the Cg is implicated in pain signaling and development of 
mechanical hypersensitivity in several pathological pain syndromes, 
we wondered whether rescuing local astrocyte dysfunction in this 
brain area could ameliorate the increased nocifensive responses 
detected in FHM2 mice upon NTG treatment (23). To that end, we 
expressed WT Atp1a2 (AAV.hGFAP.ATP1A2) in Cg astrocytes 
of FHM2 mice. As a control, FHM2 mice were injected with AAV.
hGFAP.eGFP. Three weeks after viral injections, we triggered facial 
mechanical sensitivity by NTG injections (5 mg kg−1) and per-
formed facial von Frey tests as described above (Fig. 5, F and G). 
We found that rescuing the astrocytic loss-of-function FHM2 
mutation locally in the Cg was sufficient to attenuate the acute 
hypersensitive phenotype induced by NTG in FHM2 mice (Fig. 5H 
and fig. S9), suggesting that the local astrocyte dysfunction in 
the Cg is implicated in orofacial pain sensitivity [AUC: control, 
148.8 ± 9.62 (N = 14 mice) and rescue, 91.40 ± 13.98 (N = 13 mice; 
**P = 0.0021)].
Together, our results demonstrate that astrocytes in a genetic 
migraine model display altered glutamate and K+ clearance in 
the Cg, which facilitate neuronal NMDA spike generation and 
synaptically evoked AP firing. We report that these alterations are 
pathologically relevant since local rescue of the astrocytic dysfunc-
tions reduces facial hypersensitivity induced by a migraine-relevant 
pain trigger.
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Fig. 5. Local rescue of astrocyte dysfunction in the Cg reduces facial pain in FHM2 
mice. (A) Schematic illustration of the experimental design. (B) Time course showing 
the orofacial pain score in WT mice injected with either saline (gray) or NTG (black). 
NTG (10 mg kg−1) elicits hypersensitivity to touch at 30, 60, and 120 min following in-
jection. (C) Same as (B) but for FHM2 mice injected with saline (gray) or NTG (red). NTG 
(10 mg kg−1) evokes higher orofacial pain scores at 30, 60, and 120 min following injec-
tion. (D) A lower dose of NTG (5 mg kg−1) does not elicit a higher sensitivity in WT mice. 
(E) In FHM2 mice, NTG (5 mg kg−1) evokes a higher orofacial pain score at 30 min after 
injection. (F) Schematic illustration of the experimental design. (G) Three-dimensional 
reconstruction of a cleared brain imaged with light-sheet microscopy showing the 
volume and site of the injection in Cg after ex vivo fixation. Scale bar, 300 mm. The bottom 
left image shows a single coronal section, and dots indicate the center of the injection 
volume of the viruses from six brains. (H) Time course showing the orofacial pain score 
in FHM2 mice injected with the control virus (red) or the rescue virus (blue). NTG 
(5 mg kg−1) only evoked a higher orofacial pain score at 30 min after injection in 
control FHM2 mice and not in rescued FHM2. Data are means ± SEM. Two-way ANOVA 
with Bonferroni post hoc test and two-tailed unpaired t test were used.
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DISCUSSION
Astrocytic dysfunction enhances NMDA-mediated dendritic 
excitability in Cg of FHM2 mice
In this study, we first confirmed that in the adult Cg of FHM2 mice, 
similar to the developing somatosensory cortex (3), a2 NKA dys-
function impairs both K+ and synaptically released glutamate up-
take by astrocytes. Western blot analysis performed in FHM2 mice 
also revealed a significant reduction in the expression levels of a2 
NKA and the GluT GLAST, which we previously reported to be 
implicated in astrocyte-mediated glutamate uptake in this cortical 
region (17). The reduced GLAST expression in FHM2 Cg could 
suggest potential physical coupling between a2 NKA and GLAST in 
Cg astrocytes, as was previously shown to occur between a2 NKA 
and GLT-1 in perisynaptic astrocytic processes of the somatosensory 
cortex (9). As a consequence of this tight coupling, a reduced density 
of GLT-1 transporters in perisynaptic astrocytic processes could be 
previously detected with electron microscopy in the developing barrel 
cortex of FHM2 mice (3). A local reduction of GLT-1 density spe-
cifically around synapses may remain undetected in Western blots 
and be consistent with the unaltered expression of GLT-1 in FHM2 
Cg (28). With regard to the reported impairment of K+ clearance in 
the Cg of FHM2 mice, this is likely to be directly ascribed to the re-
duced a2 NKA expression and function, which plays a major role in 
K+ clearance following trains of high-frequency stimulation (29).
The slowdown in glutamate clearance by astrocytes prolonged 
the presence of elevated glutamate levels in the extracellular space. 
Increase in glutamate spillover enhances cortical excitatory neuro-
transmission, particularly NMDA receptor–mediated transmission 
(17). Consistently, we found a facilitation of NMDA spike genera-
tion in tuft dendrites of L5 pyramidal cells both in FHM2 mice and 
upon subsaturating concentrations of the GluT blocker DL-TBOA 
(that reduces glutamate clearance to an extent similar to that pro-
duced by the FHM2 mutation) in WT mice. The probability of AP 
firing following NMDA spikes was also increased in FHM2 mice. In 
contrast, no changes were observed in spontaneous and evoked synaptic 
transmission in FHM2 mice.
To establish a causal relationship between the astrocyte malfunc-
tion and the observed neuronal modifications in FHM2, we com-
pensated for the astrocyte dysfunction by expressing the WT form 
of the Atp1a2 gene in the Cg of FHM2 mice. This intervention re-
versed the defective glutamate and K+ clearance by astrocytes.
Compensating the astrocyte dysfunction reduced the facilitation 
of dendritic NMDA spike generation, thereby lowering the output 
firing induced by these spikes. These findings demonstrate that NMDA 
spike generation on tuft dendrites of L5 pyramidal cells and the sub-
sequent neuronal output are directly and dynamically affected by 
astrocytic dysfunction.
NMDA spikes are believed to be the dominant mechanism by which 
distal synaptic inputs lead to firing of pyramidal neurons in the cortex 
(30). Since dendritic spikes increase the computational properties of 
individual neurons (19, 30), the facilitation of NMDA spike genera-
tion and the resulting firing of L5 pyramidal cells (the main output 
cells of the Cg) could greatly influence network activity in down-
stream cortical and subcortical areas involved in pain processing.
The altered cellular functions in the Cg of FHM2 mice lead 
to hypersensitivity to a migraine-relevant pain trigger
In migraineurs, NTG administration induces a delayed migraine- 
like headache with associated features such as premonitory symptoms 
and allodynia (24). NTG-induced hyperalgesia in animals provides 
a behavioral model of the NTG-induced allodynia observed in 
migraineurs during the attack (25). Using this model, we found that 
relatively low doses of NTG trigger hypersensitivity to facial mechanical 
stimulation in FHM2 mice, while they are ineffective in WT mice. A 
similar finding was previously reported for another genetic mouse 
model of migraine (26). Local rescue of the astrocytic defect by 
expressing the WT Atp1a2 gene in the Cg of FHM2 mice strongly 
reduced their increased nociceptive response upon NTG treatment. 
This finding is consistent with the conclusion that the hypersensitivity 
of FHM2 mice to a migraine-relevant trigger is largely due to altered 
neural function in the Cg.
The Cg involvement in migraine pathophysiology
The anterior Cg (ACC) and midcingulate cortex (MCC) play a key 
role in pain processing (23, 31). The ACC is consistently activated 
in humans and animal models upon nociceptive stimuli (32), and 
neuronal plasticity in the ACC is correlated with the development 
of chronic pain (21, 23). The ACC is also among the regions that are 
activated during spontaneous migraine attacks (33) and during the 
premonitory phase of the delayed migraine-like headache induced 
by NTG infusion in migraineurs (34). Moreover, functional imaging 
studies show increased activation of both the ACC (12) and the MCC 
(13, 35) in response to noxious (including trigeminal) stimulation 
in migraineurs during the interictal period. Migraineurs show in-
creased activation of the MCC that correlates with increased pain 
rating (sensitization) during repeated trigeminal noxious stimula-
tion, while healthy controls show decreased MCC activation and 
pain rating (habituation) (13). However, the underlying mechanism 
of this hyperactivity and its potential involvement in cranial pain 
induction was still elusive. We report an astrocyte-mediated facili-
tation of NMDA spike generation and a subsequent increase of L5 
pyramidal cell firing in the Cg of FHM2 mice, which may be potentially 
involved in pain generation and/or sensitization of the pain process-
ing system in familial migraine. The evidence that astrocyte dysfunc-
tion in the Cg can specifically increase facial tactile sensitivity to a 
pain trigger supports the notion that the Cg is a critical hub in pain 
processing and may additionally gate the activation of cranial pain 
pathways. Whether the ACC, the MCC, or both mediate this remains 
unclear. The ACC is broadly connected to the salience network and 
projects to the periaqueductal gray, rostral ventromedial medulla, 
and dorsal horn (5). An interesting pathway from the MCC to the 
posterior insula (and involving descending serotoninergic facilitation 
of nociception from the raphe magnus nucleus) has been shown to 
be necessary and sufficient for the induction and maintenance of 
pain sensitization and could also be involved in the observed behavior 
(31). Therefore, heightened activity in the ACC and/or MCC could 
have broad effects on migraine-relevant pain perception and descend-
ing modulatory circuits, which could lead to a loss of pain inhibition 
and/or to pain facilitation. It would therefore be intriguing to test 
how the rescue of the astrocytic mutation in the ACC or MCC affects 
the activity of those downstream regions crucial for the development 
or sensitization of cranial pain.
Our data support the idea that FHM2-associated astrocytic dys-
function in particular brain regions may engender different migraine- 
relevant functional consequences. In the somatosensory cortex, it 
lowers the CSD threshold with a potential impact on aura occurrence 
and cranial nociceptor activation (3, 10). CSD facilitation is a common 
feature of all genetic models of migraine that have been investigated 
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so far (26, 36, 37). In the hippocampus, the FHM2 mutation causes 
abnormal region-dependent synaptic plasticity, which might underlie 
some of the memory deficits observed in FHM2 patients (38). We 
demonstrate instead that Cg astrocyte dysfunction in FHM2 mice 
leads to hypersensitivity to a migraine-relevant trigger.
In conclusion, we provide evidence that astrocyte dysfunction in 
the Cg, a nonsensory cortical area, is implicated in heightened 
sensitivity to head pain triggers and may be involved in pain gener-
ation and/or sensitization of the pain processing system in familial 
migraine. Understanding the cellular and molecular nature of 
circuit-specific network dysfunctions associated with familial migraine 




Experiments were performed using adult (5 to 9 weeks old) hetero-
zygous KI mice harboring the W887R FHM2 mutation [Atp1a2+/R887 
mice; (10)] and their WT littermates (background C57BL/6J; male 
and female in equal or near-equal number). Adult mice were group-
housed up to five in filter-top cages with a standard 12-hour light/12-hour 
dark cycle and food and water available ad libitum. Permission for 
animal experiments was obtained from the Tierversuchskommission 
of the canton of Zurich, Zurich, Switzerland. All animal experiments 
complied with the relevant ethical regulations.
Chemicals and drugs
Reagents for artificial cerebrospinal fluid (ACSF) and internal solutions, 
biocytin, 6-nitro-7-sulfamoylbenzo[f]quinoxaline-2,3-dione 
(NBQX), and picrotoxin were obtained from Sigma-Aldrich. 6-cyano- 
7-nitroquinoxaline-2,3-dione (CNQX), AP-V, DL-TBOA, and D-serine 
were obtained from Tocris. NBQX, CNQX, and DL-TBOA were dis-
solved in dimethyl sulfoxide. Tetrodotoxin (TTX) was obtained from 
Abcam. NTG was obtained from Sigma-Aldrich. Picrotoxin was dissolved 
in ethanol (EtOH). AP-V, D-serine, and TTX were dissolved in ddH2O.
Acute brain slice preparation
Mice were briefly anesthetized with isoflurane and decapitated. The 
brain was quickly removed and transferred to an ice-cold solution 
containing 65 mM NaCl, 2.5 mM KCl, 1.25 mM NaH2PO4, 25 mM 
NaHCO3, 7 mM MgCl2, 0.5 mM CaCl2, 25 mM glucose, and 105 mM 
sucrose saturated with 95% O2 and 5% CO2; coronal slices (350 mm thick) 
containing the ACC were cut from the tissue block with a vibratome 
(HM 650, Microm). Slices were then transferred to a recovery solu-
tion containing 130 mM K-gluconate, 15 mM KCl, 0.2 mM EGTA, 
20 mM Hepes, and 25 mM glucose for 2 min before being kept in 
oxygenated ACSF (315 mosm) saturated with 95% O2 and 5% CO2 
and containing 125 mM NaCl, 2.5 mM KCl, 1.25 mM NaH2PO4, 25 mM 
NaHCO3, 1 mM MgCl2, 2 mM CaCl2, and 25 mM glucose at 34°C 
for 25 min and then at room temperature until use. Slices used for 
two-photon glutamate imaging and astrocytic patch-clamp recordings 
were loaded with SR-101 (1 mM) for 15 min at 34°C before being 
kept in ACSF at room temperature.
Electrophysiological recordings
Whole-cell recordings from astrocytes
Recordings were performed as previously described in (17). Individual 
slices were transferred to a recording chamber perfused with oxygenated 
ACSF, at a flow rate of 1 to 2 ml/min at 32° to 34°C. Whole-cell re-
cordings were taken from L1 astrocytes in the Cg. Unless otherwise 
stated, cell bodies of astrocytes were visualized using an astrocyte- 
specific dye (SR-101; see above) that was excited with wLS broad-
band light-emitting diode illumination (460 nm), and images were 
acquired with Retiga R1 camera using Ocular software (QImaging, 
Germany) with a 40× water immersion objective. In addition, astro-
cytes were recognized by their hyperpolarized resting membrane 
potential, their linear current-voltage relationship, their inability to 
generate APs, and their low input resistance. Recordings were taken 
with borosilicate glass pipettes (4 to 8 megohm) containing the fol-
lowing internal solution: 115 mM K-gluconate, 6 mM KCl, 5 mM 
glucose, 7.8 mM Na-phosphocreatine, 4 mM Mg-ATP (adenosine 
triphosphate), 0.4 mM Na-GTP (guanosine triphosphate) [pH 7.25 
with KOH; osmolarity, 295 mosm (readjusted with sucrose when 
necessary)]. Recordings were performed using MultiClamp 700B 
amplifier, and data were acquired with a Digidata 1550A 16-bit 
board (all from Molecular Devices). For the recording of STCs, the 
extracellular solution contained antagonists of NMDA receptors 
(AP-V; 50 mM), AMPA receptors (CNQX or NBQX; 10 mM), and 
g-aminobutyric acid type A (GABAA) receptors (picrotoxin; 100 mM). 
Astrocytes were held at −80 mV, and STCs were evoked by single- 
pulse stimulation or by trains of 10 and 11 pulses at high frequen-
cies (50 and then 100 Hz) every 20 s. The K+ inward current was 
characterized as the slowly decaying inward current elicited in as-
trocytes upon high-frequency synaptic stimulations. Every protocol 
was repeated at least five times and then averaged and analyzed. 
Currents were evoked by focal electrical stimulation (bipolar, 100 ms, 
8.5 V) through a theta glass pipette placed in L1, in the proximity of the 
recorded astrocyte. Access resistance was monitored (<16 megohm), 
and recordings with an access resistance changing more than 30% 
between the beginning and the end of the recording were discarded. 
Resting membrane potential and input resistance were monitored 
for analysis of electrophysiological properties of astrocytes. The de-
cay kinetics of the last pulse of the trains were analyzed by subtract-
ing the current elicited by 10 pulses from that elicited by the 11th 
pulse.
Whole-cell recordings from L5 pyramidal neurons
Somas were patched with borosilicate glass pipettes (2.2 to 4 megohm). 
Cells were clamped at −70 mV, and focal synaptic stimulation was 
performed through a theta patch pipette located close to the selected 
apical tuft dendritic segments in L1. NMDA spikes were evoked by 
applying paired-pulse stimulations of 50 Hz of increasing stimula-
tion intensities (from 1 to 2.5 mA or 5.5 mA). Recordings with an 
access resistance >15 megohm were discarded. The following internal 
solution was used: 130 mM K-gluconate, 5 mM KCl, 10 mM Hepes, 
10 mM phosphocreatine, 4 mM Mg-ATP, 0.3 mM GTP, and biocytin 
(1.5 mg/ml) (pH 7.3 with KOH; osmolarity, 294 mosm). To visualize the 
dendrites, patch pipettes also contained Alexa Fluor 488. Recordings 
were performed in the presence of GABAA receptor blocker (picro-
toxin; 100 mM) and D-serine (10 mM).
For mEPSCs, somata were targeted for recording with borosilicate 
glass pipettes (2.2 to 4 megohm) containing the following: 130 mM 
gluconic acid, 130 mM CsOH, 5 mM CsCl, 10 mM Hepes, 1.1 mM EGTA, 
10 mM Na-phosphocreatine, 4 mM Mg-ATP, and 0.3 mM Na-GTP. 
The pH of the intracellular solution was adjusted to 7.3 with CsOH, 
and biocytin (1.5 mg ml−1) was added for the reconstruction of neurons. 
Cells were held at −70 mV, and synaptic responses were recorded in 
the presence of picrotoxin (100 mM) and TTX (1 mM). Recordings 
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with an unstable baseline or a holding current less than −400 pA 
were rejected. Currents were filtered off-line using a Butterworth 
low-pass filter (2 kHz) and analyzed in 1-min epochs using the Mini 
Analysis Program 6.0.7 (Synaptosoft Inc., USA). Recordings with 
leak current increasing more than 100 pA and access resistance 
changing more than 30% between the beginning and the end of the 
recording were discarded. At least 100 events were analyzed for every 
condition. Events were identified as mEPSCs by setting the event 
detection threshold at least twice the baseline noise level and by 
checking that events had (i) rise times faster than the decay time, (ii) rise 
times greater than 0.5 ms, and (iii) decay times greater than 1.5 ms. 
Events not fitting the above parameters were rejected. Event amplitudes, 
interevent intervals, and rise and decay times were first averaged 
within each experiment and regrouped by condition. The resulting 
means were averaged between experiments. Single-cell properties 
(access resistance, membrane capacitance, etc.) were analyzed with 
Clampfit 10.5 (Axon Instruments, Union City, CA). Graphs were 
made using GraphPad Prism and Illustrator 15.1.0 (Adobe). For 
evoked AMPA-mediated excitatory postsynaptic currents (eEPSCs), 
cells were held at −70 mV and focal synaptic stimulation was 
performed through a theta patch pipette located close to the tuft 
dendrites in L1. AMPA eEPSCs were evoked by applying either a 
single stimulation or paired-pulse stimulations at 20 Hz. Recordings 
were acquired in the presence of picrotoxin (100 mM) and AP-V (50 mM) 
in ACSF.
Biocytin labeling
For some experiments, internal solutions used for recording of py-
ramidal cells contained biocytin (1.5 mg/ml) that diffused in the 
cells for at least 10 min, as previously described in (17). Briefly, slices 
(350 mm) containing the recorded cell were then fixed in 4% para-
formaldehyde (PFA) at +4°C overnight. The following day, slices were 
washed in phosphate-buffered saline (PBS) and 274 mM NaCl be-
fore being transferred to a blocking solution containing 10% nor-
mal goat serum in 0.3% Triton-PBS and 274 mM NaCl for 1 hour. 
Afterward, slices were put in a blocking solution containing Alexa 
Fluor 647–conjugated streptavidin (1:700; Jackson ImmunoResearch 
Europe Ltd.; code: 016-600-084) for 2 hours. Slices were then 
washed in PBS and 274 mM NaCl before being mounted on Superfrost 
Plus slides. Images were acquired on a Zeiss LSM 710 Pascal confocal 
microscope using a 0.9 numerical aperture ×10 Plan-Apochromat 
objective (for L5 pyramidal cells) and the ZEN 2012 software (Carl Zeiss). 
Whenever applicable, contrast and illumination were adjusted in 
ImageJ. Presented images are Z projections.
AAV5/2 generation and injections in vivo
The mAtp1a2 gene (WT form of a2 NKA for compensation exper-
iments) and the EGFP gene (for control experiments) were cloned 
into plasmid backbones containing a shorted glial fibrillary acidic 
protein (HgfaABC1D) promoter as in (22). These plasmids were 
packaged into AAV serotype 5 [AAV-5/2-hGFAP-mATP1A2-bGHp(A) 
and AAV5/2- hGFAP-hHBb1/E-EGFP-bGHp(A)] by the Viral Vector 
Facility of the University of Zurich. All electronic information con-
cerning the plasmids and viruses is available online in the viral vector 
repository (https://vvf.ethz.ch). FHM2 KI mice were used in all 
experiments in accordance with institutional guidelines.
All surgical procedures were conducted under general anesthesia 
using continuous isoflurane inhalation (induction at 5% and main-
tenance at 1 to 3%). Following induction of anesthesia, the mice 
were placed into a motorized stereotaxic frame (David Kopf Instru-
ments and NeuroStar) using adjustable ear bars and an anesthesia 
mask with an incisor bar. The animal was maintained at a physio-
logical temperature using a heating mat placed between the animal 
and the frame. Vitamin C ointment was applied to the eyes to prevent 
corneal drying during the operation. Mice were subcutaneously 
administered buprenorphine (0.2 mg/kg) before surgery. The fur 
between the ears was shaved, scrubbed with EtOH and betadine, 
and dried, and a longitudinal incision of approximately 3 to 5 mm 
was made in the skin above the skull. For unilateral injections, a single 
hole was drilled through the skull directly above the Cg on one 
hemisphere (stereotaxic coordinates with respect to bregma: 0.75 mm 
anterior, 0.3 mm lateral, and 1.25 mm ventral). For control experiments, 
0.5 ml of the control virus AAV5/2- hGFAP-hHBb1/E-EGFP-bGHp(A) 
was injected through a glass pipette. Since AAV vectors size is limited 
to ~4.7 kb, it was not possible to include a reporter gene in the rescue 
virus AAV-5/2-hGFAP-mATP1A2-bGHp(A). Therefore, to visualize 
the injection site, we injected a mixture of 0.5 ml of the two viruses 
with a ratio of 2:1 of the rescue virus to the control virus containing 
eGFP. Glass pipettes were left in place for at least 10 min follow-
ing infusion of the virus. Surgical wounds were closed with single 
5-0 nylon sutures. Following surgery, animals were closely monitored. 
Mice were euthanized 15 to 25 days after surgery for electrophysiology 
experiments or were used for behavioral experiments. When assess-
ing behavior, AAVs were injected bilaterally. The experimenter was 
blinded to which AAV was injected.
Two-photon glutamate imaging
Mice aged between 4 and 6 weeks were injected with 0.3 to 0.5 ml of 
AAV2/1.GFAP.iGluSnFr.WPRE.SV40 (Penn Vector; provided by 
L. Looger, Janelia Farm) unilaterally into the Cg through a glass 
pipette as described above. Fifteen to 21 days following the virus 
injections, coronal brain slices (350 mm) containing the Cg were 
obtained as previously described (21). Imaging was performed as 
described in (17). Briefly, a galvanometer-based two-photon laser 
scanning system was used to image extracellular glutamate (16× 
objective; zoom, 6; excitation wavelength, 900 nm; 64pixels by 64 pixels 
per image; acquisition rate, 19.2 Hz). Astrocytes were visualized using 
SR-101. Synaptic glutamate release was elicited by trains of 10 pulses 
at high frequency (50 or 100 Hz) every 20 s delivered via a theta 
glass pipette (bipolar, 100 ms; stimulation intensity, 3 to 5 V) placed 
in the inner L1. To visualize the theta glass pipette, it was filled with 
ACSF containing 1 mM SR-101. Note that SR-101 staining does not 
affect the kinetics of iGluSnFr transients nor of STCs as shown in 
(17). Moreover, when we doubled the acquisition rate to 38.4 Hz, 
the iGluSnFr decay kinetics remained unaltered, indicating that the 
image acquisition rate used was sufficient to detect the monitored 
changes. All solutions contained 10 mM NBQX or CNQX, 50 mM 
AP-V, and 100 mM picrotoxin, and temperature was kept between 
32° and 34°C during imaging. Ten consecutive sweeps were acquired 
and subsequently analyzed using ImageJ. Fluorescence emission 
was collected from an ROI (diameter, 34 mm) 10 to 40 mm away 
from the stimulation pipette. The average background value was 
derived from a region within the field of view that was free 
of clearly visible iGluSnFr (typically in the contralateral hemi-
sphere) and subtracted from the fluorescence intensity of the ROIs 
for each frame. Traces were then averaged, and decay tau was cal-
culated by fitting a single exponential function using Igor Pro 
(WaveMetrics).
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Behavioral testing was performed in a dimly lit and quiet room by 
the same female experimenter. Throughout the week before the first 
behavioral testing, mice were habituated to handling by the experi-
menter. Each mouse was placed in Plexiglas cages of about 20 cm by 
20 cm sitting on a metal grid ground floor. Mice were allowed to 
accommodate to the cage for 1 hour before the testing. In all experiments, 
0.025- and 0.01-g von Frey filaments were used. The first tests were 
performed using the lower-force filament. Filaments were applied 
to the orofacial area close to the whisker pad or close to a 90° angle 
until bent, in three series of four pokes, in the middle or on either 
left or right side of the snout. After a total of 12 pokes with the 
0.025-g filament, the stimulation with the 0.01-g filament was 
applied in the same way. The responses recorded were as follows: 
unilateral or bilateral forepaw swipes across the face (1 point each), 
continuous forepaw swipes (three or more: 1.5 points), aggression/
biting of the probe following stimulus (0.25 points), and clear with-
drawal of the head from the stimulus (0.25 points) as described 
in (27). Before the injection of NTG (5 or 10 mg/kg) or 0.9% saline 
(intraperitoneally), baseline 1 was recorded several hours or a day 
before the experiment and baseline 2 was immediately before intra-
peritoneal injections. Testing was carried out at 30, 60, 120, and 
180 min after injection. The experimenter was blinded to the treat-
ment in all behavioral experiments.
Locomotor activity
NTG (5 mg/kg, i.p.) or saline was administered 30 min before testing. 
Locomotor activity was measured in an open-field arena (radius, 
10 cm) equipped with four pairs of light beams and photosensors 
and analyzed for the time interval between 10 and 60 min after NTG 
or saline administration.
Brain clearing and light-sheet microscopy
After fixation and dehydration
Mice were anesthetized with isoflurane and decapitated. Entire brains 
were extracted, briefly washed in PBS to remove excessive blood, and 
postfixed in 4% PFA for 2 days at 4°C. After fixation, brains were washed 
two times in PBS and subsequently dehydrated in increasing alcohol 
concentrations [30, 50, 70, 80, 90, 96, and 100% EtOH (each adjusted 
to pH 9.5)] for a day each (39). Tissue shrinkage of up to 50% was 
observed during the dehydration process. After dehydration, brains were 
transferred into a clearing solution of benzyl alcohol and benzyl benzoate 
(1:2) solution (BABB) in separate glass vials on a gentle shaking or rotat-
ing cycle under a chemical hood for a minimum of 1 day until transparent.
Imaging
Cleared brains were transferred to an immersion cuvette containing 
BABB and placed in the imaging reservoir of the microscope. Images 
were acquired using the mesoscale single-plane illumination micro-
scope mesoSPIM system (www.mesospim.org) with an Olympus MVX10 
macroscope in the detection path and an MVPLAPO 1× objective 
(40). The fluorescent signal in the sample was recorded at ×1.6 magnifica-
tion by moving the sample through the light sheet in 4-mm steps. The 
sample was illuminated from one side using Toptica multi-laser engine 
laser at excitation wavelengths of 488 and 640 nm. Postprocessing of 
images was carried out using ImageJ and Imaris software (Bitplane).
Western blots
Two weeks following stereotaxic viral injections in the Cg, tissue 
of the Cg was rapidly dissected and immediately frozen on dry ice 
and stored at −80°C until used. On the day of the experiment, the 
tissue (10 to 20 mg) was thawed and homogenized by sonication in 
20 volumes of 20 mM tris (pH 7.4) containing the protease inhibitor 
cocktail cOmplete Mini (Roche Diagnostics). The homogenate was 
centrifuged for 10 min at 1000g, and the supernatant was recovered. 
After total protein quantification using the Bradford protein assay 
(Bio-Rad), the samples were incubated with Laemmli sample buffer 
(Bio-Rad) for 30 min at 37°C. Aliquots containing 10 mg (GLAST) 
or 15 mg of protein (ATPase a2 and GLT-1) were subjected to SDS–
polyacrylamide gel electrophoresis using 10% (GLAST and GLT-1) 
or 7.5% (ATPase a2) mini gels (Mini-PROTEAN 3, Bio-Rad). Pro-
teins were transferred onto nitrocellulose membranes in a Trans-
Blot semi-dry transfer cell (Bio-Rad) at 15 V for 60 min using 39 mM 
glycine, 48 mM tris, 1.3 mM SDS, and 20% methanol as transfer 
buffer. After blotting, the transferred proteins were stained with 
REVERT Total Protein Stain (LI-COR) and immediately imaged 
using the Odyssey CLx imager (LI-COR). For immunodetection, 
the blots were blocked for 1 hour in PBS containing 5% nonfat dry 
milk at room temperature, followed by incubation at 4°C overnight 
with anti–a2 NKA antibodies (1:1000; rabbit polyclonal, Sigma- 
Aldrich, catalog no. 07-674), anti–GLT-1 antibodies (1:1000; rabbit 
polyclonal, knockout verified, Synaptic Systems, catalog no. 
250203), or anti-GLAST antibodies (1:10,000; rabbit polyclonal, 
knockout verified, Synaptic Systems, catalog no. 250113), diluted in 
PBST [PBS (pH 7.4) and 0.05% Tween 20] containing 5% nonfat 
dry milk. The blots were then washed five times for 5 min with Tris 
Buffered Saline + Tween 20 (TBST) (10 mM Tris, pH 7.4, 150 mM 
NaCl, 0.05% Tween 20) and incubated with secondary antibodies 
(1:20,000; goat anti-rabbit Alexa Fluor Plus 800) for 1 hour at room 
temperature. Following extensive washing (see above), immuno-
reactivity was detected using the Odyssey CLx imager (LI-COR). 
Immunoreactivity was quantified with the Image Studio software 
(LI-COR) and normalized to total protein in the corresponding 
lanes. Each antibody was tested for its linear detection range using 
different protein and antibody concentrations.
Immunohistochemistry and image analysis
Three weeks after stereotaxic viral injections in the Cg, FHM2 KI mice 
were anaesthetized with pentobarbital (160 mg kg−1, i.p.) before 
transcardiac perfusion with 20 ml of phosphate buffer followed by 
100 ml of 4% ice-cold PFA [in 0.1 M sodium phosphate buffer (pH 7.4)]. 
Brain tissue was postfixed for 4 hours with 4% PFA on ice and cryo-
protected in 30% sucrose solution (in 0.1 M sodium phosphate buffer) 
overnight at 4°C. Brains were embedded in NEG50 frozen section 
medium (Richard-Allan Scientific) and cut into 40-mm free-floating 
sections (Hyrax KS 34 microtome, Carl Zeiss). Brain sections were 
left in antifreezing solution at −20°C until use. Following incubation 
in blocking solution (PBS, 0.3% Triton X-100, and 10% normal 
donkey serum) for 1 hour, brain sections were incubated at 4°C 
overnight in a primary antibody solution (PBS, 0.3% Triton X-100, 
and 10% normal donkey serum) containing combinations of the 
following antibodies: chicken anti-GFP (1:1000; LifeTech, 
AB_2534023), guinea pig anti-NeuN (1:1000; Synaptic Systems, 
AB_2619988), and rabbit anti-S100B (1:700; Abcam, AB_52642). 
Three washing steps of 10 min each in PBS were performed before 
incubating brain sections with secondary antibodies (1:500): Cyanine 
Cy3 donkey anti-rabbit (Jackson ImmunoResearch, AB_2307443), 
Alexa Fluor 647 donkey anti-guinea pig (Jackson ImmunoResearch, 
AB_2340477), and Alexa Fluor 488 donkey anti-chicken (Jackson 
Romanos et al., Sci. Adv. 2020; 6 : eaaz1584     5 June 2020
S C I E N C E  A D V A N C E S  |  R E S E A R C H  A R T I C L E
12 of 13
ImmunoResearch, AB_2340376) for 90 min at room temperature in 
PBS supplemented with 0.3% Triton X-100. Images were taken with an 
LSM 800 with Airyscan confocal microscopes (Carl Zeiss) controlled 
with ZEN 2.3 (blue edition) software and using a Plan-Apochromat 
×40/1.4 Oil DIC M27 oil-immersion objective. Z stack images of 
10 optical sections and 1.5-mm step size were used for the analysis of 
fluorescence colocalization and to create maximum intensity pro-
jections images. Images were processed using ImageJ software.
Quantification and statistical analysis
Data are displayed as means ± SEM in all experiments except for the 
Western blot data that are displayed as means ± SD. Statistical details 
can be found in Results, figures, and figure legends. Statistical com-
parisons were made with two-tailed paired or unpaired t tests, one-
way analysis of variance (ANOVA) with Bonferroni post hoc test, 
one-way ANOVA with Tukey post hoc test, or two-way repeated- 
measures ANOVA test. All graphs and statistical tests were performed 
using GraphPad Prism, and figures were prepared using Adobe 
Illustrator CS5. P values less than 0.05 were considered statistically 
significant.
SUPPLEMENTARY MATERIALS
Supplementary material for this article is available at http://advances.sciencemag.org/cgi/
content/full/6/23/eaaz1584/DC1
View/request a protocol for this paper from Bio-protocol.
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